Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis

Identifying a reliable biomarker may accelerate diagnosis of multiple sclerosis (MS) and lead to early management of the disease. Accumulating evidence suggest that cerebrospinal fluid (CSF) and peripheral blood concentration of osteopontin (OPN) may have diagnostic and prognostic value in MS. We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Agah, Elmira, Zardoui, Arshia, Saghazadeh, Amene, Ahmadi, Mona, Tafakhori, Abbas, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773083/
https://www.ncbi.nlm.nih.gov/pubmed/29346446
http://dx.doi.org/10.1371/journal.pone.0190252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773083/
https://www.ncbi.nlm.nih.gov/pubmed/29346446
http://dx.doi.org/10.1371/journal.pone.0190252

Ejemplares similares